The InterLynk roadmap outlines a comprehensive journey toward advancing regenerative and precision medicine. From developing cutting-edge biomaterials and leveraging multimaterial additive manufacturing to rigorous validation and stakeholder-driven co-creation, each step is designed to bridge the gap between science and clinical application. Discover how InterLynk is paving the way for transformative solutions in tissue repair and regeneration.
BIOMATERIALS
A Portfolio of Innovative Biomaterials
InterLynk scientists are crafting a range of biofunctional composite inks and biomaterials specifically designed for additive manufacturing. These materials are enriched with human-derived platelet lysates, which enhance their biocompatibility and regenerative potential.
BIOPRINTING
Multimaterial Additive Manufacturing in regenerative medicine
Cutting-edge virtual modeling tools and advanced additive manufacturing technologies are being employed to create scaffolds with unprecedented precision. These multimaterial scaffolds are tailored to patient-specific needs and mimic the intricate biochemical and mechanical environments of multi-tissue systems.
IN VIVO / IN VITRO
Validation and Testing
The efficacy of the developed scaffolds will be rigorously tested for their ability to repair complex tissue interfaces, with a specific focus on the temporomandibular joint. This process includes both in vitro and in vivo studies to ensure functionality under demanding physiological conditions.
STAKEHOLDER INVOLVEMENT
Health Technology Co-Creation
InterLynk emphasizes collaboration with key stakeholders, including clinicians, patients, health economists, and regulatory experts. This co-creation process ensures that solutions are not only scientifically sound but also aligned with real-world needs and regulatory standards, facilitating future clinical adoption.